Learn how KMA and LMA represent a breakthrough in treatment approaches for multiple myeloma and related disorders.

New research suggests the skin does much more than detect damage or keep pathogens out. By tracing how skin cells respond to ...

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

The Monoclonal Antibodies Market has emerged as one of the most transformative sectors within the global biopharmaceutical ...

A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...

Liminatus today announced plans to initiate a Phase 1 clinical trial evaluating IBA101, a next-generation CD47-blocking monoclonal antibody designed to engage innate immune pathways and complement ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Focus shifted to development of first tri-specific antibody from the CAPTN-3 platform, IM1240, targeting 5T4 tumor-associated antigen, and second ...

A collaborative effort led by Professor Wanli Liu 's team at Tsinghua University has uncovered a sophisticated mechanism by ...

Prior exposure to one strain of influenza virus may weaken children's ability to mount an effective antibody response against ...